A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants
Clinical trial NCT06081699 · COMPLETED
Trial details
- NCT number
- NCT06081699
- Sponsor
- TenNor Therapeutics (Suzhou) Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-09
- Primary completion
- 2019-09-18
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.